Press Releases

ToxExpo keeps members and attendees up-to-date on the latest news with Press Release postings.
Exhibitors receive one press release as part of their booth profile, additional may be purchased.

• EU’s €60m Effort to Promote Non-Animal Toxicity Testing: ASPIS Cluster Participates at 2023 Society of Toxicology Annual Meeting and ToxExpo in Nashville
  Submitted on: Mar 20, 2023, by PrecisionTox (#1435)

  EU’s €60m Effort to Promote Non-Animal Toxicity Testing: ASPIS Cluster Participates at 2023 Society of Toxicology Annual Meeting and ToxExpo in Nashville The ASPIS Cluster, bringing together three consortia (PrecisionTox, RISK HUNT3R and ONTOX) funded by the European Commission’s Horizon2020 Programme, will participate... Learn More

• Axine to Showcase Solutions to Tackle Emerging Contaminants in Industrial Wastewater at ToxExpo
  Submitted on: Mar 19, 2023, by Axine Water Technologies (#1542)

  Company will highlight its capabilities in the remediation of wastewater contaminated with small molecule pollutants VANCOUVER, B.C., Canada, March 20, 2023 — The presence of emerging contaminants such as pharmaceuticals and per- and polyfluoroalkyl substances (PFAS) in our water supply poses a growing threat to public health... Learn More

• ALVEOLIX: LAUNCH OF THE NEW ORGAN-ON-CHIP SYSTEM
  Submitted on: Mar 16, 2023, by AlveoliX (#1406)

  The new AXBarrier-on-Chip System includes breakthrough 3D stretch features to easily mimic any organ barrier of your choice. Bern, Switzerland – March 16, 2023 AlveoliX announced the launch of its latest product, the AXBarrier-on-Chip System. The... Learn More

• GI toxicity screening in vitro: Altis Biosystems presents a stem cell model for predicting risk of intestinal side effects at 2023 Society of Toxicology Annual Meeting
  Submitted on: Mar 13, 2023, by Altis Biosystems, Inc. (#1227)

  Research Triangle Park, NC, 2023 –Altis Biosystems will be presenting data using the RepliGut® Model system for intestinal toxicity screening at the Society of Toxicology’s 62nd Annual Meeting and ToxExpo. The RepliGut® Model is a human stem cell derived platform that recreates the intestinal epithelium, enabling physiologically relevant testing of... Learn More

• Life Sciences Review February 2023
  Submitted on: Mar 10, 2023, by cellQART made by SABEU (#1636)

  SABEU – A champion in cell culture disposable manufacturing Read or download a copy on our website > ... Learn More

• IIVS and Toxys enter into agreement to offer ToxTracker® for in vitro genetic toxicity evaluation
  Submitted on: Mar 09, 2023, by Toxys (#515)

  IIVS will offer ToxTracker®, expanding its portfolio of animal-free genetic toxicology assays Gaithersburg, M.D., USA, and Oegstgeest, The Netherlands, March 9, 2023 – The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker® assay.... Learn More

• Araceli Biosciences Unveils New Cutting-Edge Headquarters to Fuel Scientific Innovation and Growth
  Submitted on: Mar 08, 2023, by Araceli Biosciences (#909)

  Hillsboro, OR (February 28, 2023) – Araceli Biosciences, a leading biotechnology company, has announced its relocation to a new, larger headquarters location to accommodate expanding operations and better serve customers. Araceli will be moving to Tech Center Drive in Tigard, OR, located near the intersection of Interstate 5 and Route 217.... Learn More

• SAFE Pharmaceutical Services – Let Us Help You Navigate the Global NHP Shortage
  Submitted on: Mar 08, 2023, by SAFE Pharmaceutical Services Corp (#1516)

  North American pharmaceutical developers have had to grapple with the limited access to NHPs in biomedical research. While discussions continue in the U.S. to develop infrastructure and strategy to lessen the reliance on outside resources, NHP sources in Southeast Asia are entangled in legal battles to ease NHP export restrictions.... Learn More

• Virscio Announces Launch of Pathology and Tissue Pharmacodynamics Services Division
  Submitted on: Mar 08, 2023, by Virscio, Inc. (#1321)

  Virscio accelerates investment in advanced histology capabilities to complement in vivo translational R&D service strengths New Haven, Conn., and Christ Church, St. Kitts & Nevis, West Indies — Virscio, a leading provider of translational research and development services, announces the... Learn More

• Chem Quant continues to lead in laboratory innovation with its breakthrough new lab management software system QuantLink and innovative dried blood spot solutions.
  Submitted on: Mar 07, 2023, by Chem Quant Analytical Solutions LLC (#1316)

  Chem Quant Analytical Solutions, LLC is proud to announce the launch of its latest lab management software system QuantLink. QuantLink’s low code platform allows for modern innovations and connectivity not seen in other LIS systems. With a range of powerful features, including an easy-to-use dashboard, advanced analytics, customizable workflows, e-commerce... Learn More

• Elixir Software Marks 10 Years of Transforming Scientific Project Management in the Pharmaceutical Industry with iTraX
  Submitted on: Mar 03, 2023, by Elixir Software (#1436)

  Elixir Software, a leading provider of scientific project management software, is proud to announce a decade of changing the way scientists in the pharmaceutical industry communicate to improve R&D efficiency. In the past 10 years, the company's innovative platform, iTraX, has transformed the way businesses operate... Learn More

• Add These WuXi AppTec Sessions to Your SOT 2023 Agenda
  Submitted on: Mar 01, 2023, by WuXi AppTec (#739)

  From discovery and preclinical to clinical and beyond, WuXi AppTec supports researchers across the entire continuum of the drug development journey with a world-class, globally integrated testing platform. The support starts at SOT 2023. In addition to sharing information and good conversations at... Learn More

• In Diagnostics Unveils Revolutionary Miniaturized Spectrophotometer
  Submitted on: Mar 01, 2023, by In Diagnostics, Inc. (#1445)

  Carlsbad, CA In Diagnostics, an integrated diagnostics biotechnology startup, recently launched its revolutionary miniaturized spectrophotometer and secured intial sales. This innovative product represents a major milestone in the field of low volume testing and demonstrates the company's commitment to advancing the field of diagnostics. The single wavelength... Learn More

• ​Lonza to Expand Early Development Services Offering into North America
  Submitted on: Feb 24, 2023, by Lonza (#1125)

  A new facility in Cambridge, Massachusetts (US) will open in May 2023, making Learn More

• MOLTOX® ISO 9001:2015 Certification
  Submitted on: Feb 21, 2023, by MOLTOX Molecular Toxicology, Inc. (#1206)

  MOLTOX® is proud to announce the achievement of ISO 9001:2015 certification. ISO 9001:2015 is a globally recognized certification of quality management system standards.  To achieve ISO 9001:2015 certification, MOLTOX® underwent a rigorous evaluation process and company-wide audit. These standards further communicate the commitment that... Learn More

• Frontage presents an extensive safety and toxicology portfolio to prepare Sponsors for NDA submissions
  Submitted on: Feb 20, 2023, by Frontage (#1027)

  Frontage expanded services provide comprehensive toxicology testing services for our clients, from late discovery through IND preparedness to NDA submissions. Committed to helping Sponsors build confidence in their drugs early, Frontage has integrated safety and toxicology operations between Experimur (Chicago, IL) and Frontage (Concord, OH) and Frontage China,... Learn More

• Welcome to Vivo Bio Tech - Your Drug Discovery Partner
  Submitted on: Feb 14, 2023, by Vivo Bio Tech Limited (#1427)

  Vivo BioTech, leading Indian CRO offering preclinical regulatory& non-regulatory in-vitro,in-vivo, ecotoxicology, analytical, bio-analytical, ADME, PK-PD, telemetry studies for pharma, biotech, vaccine, biocide, medical device and agrochemical companies with state of art 150,000 square feet OECD-GLP certified preclinical facility for studies on small & large animal viz., rats, mice, guinea pigs, rabbits,... Learn More

• Symposium: Medical Device validation using superficial vascular access in animal models
  Submitted on: Feb 14, 2023, by Vivo Bio Tech Limited (#1427)

  Vivo Bio Tech, Hyderabad, India,invites all delegates and industry to our exciting sponsored symposium on Medical Devices (Please leave your details/business cards at our booth 101A) Session Information Who should attend: Those interested in medical device validation requiring a superficial vascular access Session Description: To explore the possibility... Learn More

• Toxi-Coop Toxicological Research Center, Booth No 748
  Submitted on: Feb 10, 2023, by TOXI-COOP Toxicological Research Center (#748)

  It is our pleasure to meet you at our booth No 748. Toxi-Coop is a European CRO offering GLP, OECD, ICH and FDA compliant pre-clinical in vivo and in vitro toxicology testing for pharmaceuticals, chemicals (REACH),  food ingredients, biocides, medical devices and cosmetics for registration. Our services include general toxicology,... Learn More

• Martin Wilks: Acute and Chronic Toxicity of Neonicotinoid Insecticides
  Submitted on: Feb 09, 2023, by International Union of Toxicology (IUTOX) (#646)

  IUTOX would like to announce the opening of registration for the webinar, Martin Wilks: Acute and Chronic Toxicity of Neonicotinoid Insecticides ... Learn More

• Lhasa Limited announce the launch of innovative solution to support ICH S1 carcinogenicity assessments
  Submitted on: Feb 09, 2023, by Lhasa Limited (#403)

  Lhasa Limited is thrilled to announce the launch of Kaptis! Aligned with the recent finalisation of the ICH S1B(R1) guideline, Kaptis includes ICH S1 functionality. The ICH S1 functionality supports more efficient evaluation of compound carcinogenic potential and can be used to determine whether a full carcinogenicity animal... Learn More

• TissueVision Opens State-of-the-Art 10,500 sq-ft Headquarters, the Largest Facility of its Kind in the World, to Support Growth of Imaging Services Business
  Submitted on: Feb 09, 2023, by TissueVision Inc. (#1533)

  TissueVision, Inc. announced today that it has opened an expanded 10,500 sq-ft headquarters and manufacturing facility to increase capacity for its rapidly growing imaging services business. “We are thrilled about the new facility. It allows us to deepen our commitment to provide our life sciences and pharmaceutical... Learn More

• Scientists Protecting Public Health through Research on Vaping, PFAS, Parkinson’s Disease, and More Are 2023 SOT Award Recipients
  Submitted on: Feb 01, 2023, by SOT Pavilion (#933)

  Reston, Va.; January 19, 2023—Over the last 50+ years, the SOT Awards have honored visionary toxicologists, exemplary early career scientists, and outstanding postdocs and students. That tradition continues this year as SOT recognizes individuals who have and are advancing the field of toxicology in extraordinary ways. ... Learn More

• Humanized IgG Göttingen Minipigs - a novel model for toxicology studies of therapeutic antibodies
  Submitted on: Feb 01, 2023, by Ellegaard Göttingen Minipigs A/S (#824)

  We are very excited to introduce the Humanized IgG Göttingen Minipigs, a genetically altered Göttingen Minipigs strain carrying a mini repertoire of human genes for the immunoglobulin heavy chains γ1 and γ4 and the immunoglobulin light chain κ. Genetically altered Göttingen Minipigs show... Learn More

• EBTC 2.0 - A New Collaboration and Scientific Publishing Model for Toxicological Research
  Submitted on: Jan 10, 2023, by Evidence Based Toxicology Collaboration (#540)

  Problems in how the way research is generated, published, interpreted, and used affect toxicology as much as any other scientific discipline. There are increasingly large numbers of papers using questionable methods, getting through peer-review without sufficiently rigorous checks, that are being interpreted into policy using outdated approaches for synthesising evidence. ... Learn More